WEIGAO GROUP Completes HKD 0.77 Million H-Share Buyback; Treasury Stock Climbs to 56.11 Million Shares

Bulletin Express05-19

Shandong Weigao Group Medical Polymer Company Limited (WEIGAO GROUP) disclosed a share repurchase executed on 19 May 2026. The company bought back 225,200 H shares on the Hong Kong Stock Exchange at prices ranging between HKD 3.41 and HKD 3.45 per share, equating to a volume-weighted average cost of HKD 3.44 per share and a total consideration of HKD 0.77 million.

\n\nFollowing the transaction, issued shares excluding treasury shares fell from 4,466.44 million to 4,466.22 million, a marginal 0.005 % reduction. Treasury shares increased to 56.11 million, while total issued shares remained unchanged at 4,522.33 million.

\n\nThe buyback forms part of the mandate approved on 27 May 2025, which authorises the repurchase of up to 451.56 million shares. Including the latest transaction, WEIGAO GROUP has repurchased 49.47 million shares under this mandate, representing 10.95 % of the authorised limit.

\n\nUnder Hong Kong listing rules, the company is subject to a 30-day moratorium on new share issues or sales/transfers of treasury shares until 19 June 2026.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1119983046?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-05-19 17:43","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1119983046","market":"us","top_or_hot":-1,"title":"WEIGAO GROUP Completes HKD 0.77 Million H-Share Buyback; Treasury Stock Climbs to 56.11 Million Shares","media":"Bulletin Express","content":"<p>Shandong Weigao Group Medical Polymer Company Limited (WEIGAO GROUP) disclosed a share repurchase executed on 19 May 2026. The company bought back 225,200 H shares on the Hong Kong Stock Exchange at prices ranging between HKD 3.41 and HKD 3.45 per share, equating to a volume-weighted average cost of HKD 3.44 per share and a total consideration of HKD 0.77 million.</p>\n<p>\\n\\nFollowing the transaction, issued shares excluding treasury shares fell from 4,466.44 million to 4,466.22 million, a marginal 0.005 % reduction. Treasury shares increased to 56.11 million, while total issued shares remained unchanged at 4,522.33 million.</p>\n<p>\\n\\nThe buyback forms part of the mandate approved on 27 May 2025, which authorises the repurchase of up to 451.56 million shares. Including the latest transaction, WEIGAO GROUP has repurchased 49.47 million shares under this mandate, representing 10.95 % of the authorised limit.</p>\n<p>\\n\\nUnder Hong Kong listing rules, the company is subject to a 30-day moratorium on new share issues or sales/transfers of treasury shares until 19 June 2026.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>WEIGAO GROUP Completes HKD 0.77 Million H-Share Buyback; Treasury Stock Climbs to 56.11 Million Shares</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWEIGAO GROUP Completes HKD 0.77 Million H-Share Buyback; Treasury Stock Climbs to 56.11 Million Shares\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-05-19 17:43</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Shandong Weigao Group Medical Polymer Company Limited (WEIGAO GROUP) disclosed a share repurchase executed on 19 May 2026. The company bought back 225,200 H shares on the Hong Kong Stock Exchange at prices ranging between HKD 3.41 and HKD 3.45 per share, equating to a volume-weighted average cost of HKD 3.44 per share and a total consideration of HKD 0.77 million.</p>\n<p>\\n\\nFollowing the transaction, issued shares excluding treasury shares fell from 4,466.44 million to 4,466.22 million, a marginal 0.005 % reduction. Treasury shares increased to 56.11 million, while total issued shares remained unchanged at 4,522.33 million.</p>\n<p>\\n\\nThe buyback forms part of the mandate approved on 27 May 2025, which authorises the repurchase of up to 451.56 million shares. Including the latest transaction, WEIGAO GROUP has repurchased 49.47 million shares under this mandate, representing 10.95 % of the authorised limit.</p>\n<p>\\n\\nUnder Hong Kong listing rules, the company is subject to a 30-day moratorium on new share issues or sales/transfers of treasury shares until 19 June 2026.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"01066","symbol_name":"威高股份","start_time":0,"source_url":"","article_id":"1119983046","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1119983046","pubTimestamp":1779183800,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"Shandong Weigao Group Medical Polymer Company Limited (WEIGAO GROUP) disclosed a share repurchase executed on 19 May 2026. The company bought back 225,200 H shares on the Hong Kong Stock Exchange at...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"01066":"威高股份"},"translate_title":"威高集团完成77万港元H股回购；库存股攀升至5611万股","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"01066":1},"content_text":"Shandong Weigao Group Medical Polymer Company Limited (WEIGAO GROUP) disclosed a share repurchase executed on 19 May 2026. The company bought back 225,200 H shares on the Hong Kong Stock Exchange at prices ranging between HKD 3.41 and HKD 3.45 per share, equating to a volume-weighted average cost of HKD 3.44 per share and a total consideration of HKD 0.77 million.\n\\n\\nFollowing the transaction, issued shares excluding treasury shares fell from 4,466.44 million to 4,466.22 million, a marginal 0.005 % reduction. Treasury shares increased to 56.11 million, while total issued shares remained unchanged at 4,522.33 million.\n\\n\\nThe buyback forms part of the mandate approved on 27 May 2025, which authorises the repurchase of up to 451.56 million shares. Including the latest transaction, WEIGAO GROUP has repurchased 49.47 million shares under this mandate, representing 10.95 % of the authorised limit.\n\\n\\nUnder Hong Kong listing rules, the company is subject to a 30-day moratorium on new share issues or sales/transfers of treasury shares until 19 June 2026.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"shareholding,SGX","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.43.1","shortVersion":"4.43.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1119983046","isCrawlerRequest":true}